TABLE 8.

Occurrence of Selected Outcomes for Survivors (Discharged Home) According to GA

GA, wkNo. (%)
Admitted to NICUCUS * at ≥3 wkAny CUS Pathologic FindingPVH Grade >2PVL, 1 or 2 Cysts on 1 SidePVL, >2 Cysts or BilateralVentricular DilationSuspected Brain Damage Any ROPROP TreatedDeaf No Severe Neurosensory Complications §No Severe Illness
23996 (67)1 (11)0 (0)0 (0)015 (56)3 (33)05 (56)4 (44)
24353223 (66)5 (14)1 (3)4 (11)7 321 (60)6 (17)123 (66)17 (49)
25555036 (66)5 (9)2 (4)2 (4)6 321 (38)5 (9)144 (80)37 (67)
26816023 (28)3 (4)1 (1)3 (4)3122 (27)0 (0)074 (91)69 (85)
271108236 (32)5 (5)2 (2)7 (6)5 126 (24)0 (0)0100 (91)95 (86)
>27866519 (22)2 (2)1 (1)2 (2)6213 (15)0 (0)081 (94)73 (85)
Total376298143(38)21 (6)8 (2)17 (5)2711108 (29)14 (4)2327 (87)295 (79)
  • CUS indicates cerebral ultrasonography.

  • * All except 5 patients (GA of 26, 26, 27, 29, and 32 weeks) were registered as having undergone cerebral ultrasonography before 3 weeks.

  • Clinical signs of cerebral damage.

  • Deaf, as judged from brainstem audiometry or otoacoustic emission test.

  • § Defined as PVH less than grade 3, PVL limited to 1 or 2 cysts on 1 side, no ventricular dilation requiring a shunt, no clinical signs of brain damage at discharge, ROP less than stage 4 or no cryotherapy, and not deaf.

  • No severe neurosensory complications, no requirement for oxygen or assisted ventilation at 40 weeks, and no ileostomy at discharge (4 infants had ileostomies).

  • One treated with ventriculoperitoneal shunt.